FDA to let AstraZeneca’s coronavirus vaccine trials resume in the US
US regulators said on Wednesday that AstraZeneca can resume the US arm of its trial of Oxford University’s coronavirus vaccine, according to documents obtained by the Wall Street Journal. AstraZeneca paused global trials on September 8 due to what it called at the time an ‘unexplained illness’ in a British volunteer. Tests resumed on September … Read more